These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

457 related items for PubMed ID: 20654954

  • 21. A pharmacoeconomic appraisal of the strategy to tackle the H1N1v (A/California/07/09) pandemic in Italy: relevance of the CIRI-IV surveillance system.
    Lai PL, Panatto D, Gasparini R.
    J Prev Med Hyg; 2011 Sep; 52(3):142-3. PubMed ID: 22010545
    [No Abstract] [Full Text] [Related]

  • 22. [New influenza. What you should know about vaccination (interview by Dr. Judith Neumaier)].
    Haas W.
    MMW Fortschr Med; 2009 Aug 20; 151(34-35):12. PubMed ID: 19771780
    [No Abstract] [Full Text] [Related]

  • 23. Influenza vaccine 2008-2009.
    Med Lett Drugs Ther; 2008 Oct 06; 50(1296):77-9. PubMed ID: 18833032
    [Abstract] [Full Text] [Related]

  • 24. Safety of pandemic H1N1 vaccines in children and adolescents.
    Wijnans L, de Bie S, Dieleman J, Bonhoeffer J, Sturkenboom M.
    Vaccine; 2011 Oct 06; 29(43):7559-71. PubMed ID: 21821086
    [Abstract] [Full Text] [Related]

  • 25. Influenza: options to improve pandemic preparation.
    Rappuoli R, Dormitzer PR.
    Science; 2012 Jun 22; 336(6088):1531-3. PubMed ID: 22723412
    [Abstract] [Full Text] [Related]

  • 26. Effectiveness of an adjuvanted monovalent vaccine against the 2009 pandemic strain of influenza A(H1N1)v, in Stockholm County, Sweden.
    Ortqvist A, Berggren I, Insulander M, de Jong B, Svenungsson B.
    Clin Infect Dis; 2011 May 22; 52(10):1203-11. PubMed ID: 21507917
    [Abstract] [Full Text] [Related]

  • 27. Pandemic 2009 influenza H1N1 virus vaccination: compliance and safety in a single hemodialysis center.
    Stavroulopoulos A, Stamogiannos G, Aresti V.
    Ren Fail; 2010 May 22; 32(9):1044-8. PubMed ID: 20863207
    [Abstract] [Full Text] [Related]

  • 28. Immunogenicity and safety of a monovalent vaccine for the 2009 pandemic influenza virus A (H1N1) in children and adolescents.
    Lu CY, Shao PL, Chang LY, Huang YC, Chiu CH, Hsieh YC, Lin TY, Huang LM.
    Vaccine; 2010 Aug 16; 28(36):5864-70. PubMed ID: 20600484
    [Abstract] [Full Text] [Related]

  • 29. Spontaneous reporting of adverse events following immunisation against pandemic influenza in Denmark November 2009-March 2010.
    Folkenberg M, Callréus T, Svanström H, Valentiner-Branth P, Hviid A.
    Vaccine; 2011 Feb 01; 29(6):1180-4. PubMed ID: 21172382
    [Abstract] [Full Text] [Related]

  • 30. How to win trust over flu.
    Nature; 2009 Oct 08; 461(7265):698. PubMed ID: 19812628
    [No Abstract] [Full Text] [Related]

  • 31. Antibody response after a single dose of an AS03-adjuvanted split-virion influenza A (H1N1) vaccine in heart transplant recipients.
    Meyer S, Adam M, Schweiger B, Ilchmann C, Eulenburg C, Sattinger E, Runte H, Schlüter M, Deuse T, Reichenspurner H, Costard-Jäckle A.
    Transplantation; 2011 May 15; 91(9):1031-5. PubMed ID: 21358365
    [Abstract] [Full Text] [Related]

  • 32. Uptake of pandemic influenza (H1N1)-2009 vaccines in Brazil, 2010.
    Domingues CM, de Oliveira WK, Brazilian Pandemic Influenza Vaccination Evaluation Team.
    Vaccine; 2012 Jul 06; 30(32):4744-51. PubMed ID: 22609010
    [Abstract] [Full Text] [Related]

  • 33. [The influenza pandemic in a Norwegian municipality autumn 2009].
    Rørtveit S, Hunskår S, Wensaas KA, Simonsen KA, Rørtveit G.
    Tidsskr Nor Laegeforen; 2011 Apr 08; 131(7):675-9. PubMed ID: 21494301
    [Abstract] [Full Text] [Related]

  • 34. Influenza A/H1N1 MF59-adjuvanted vaccine in preterm and term children aged 6 to 23 months.
    Esposito S, Pugni L, Daleno C, Ronchi A, Valzano A, Serra D, Mosca F, Principi N.
    Pediatrics; 2011 May 08; 127(5):e1161-8. PubMed ID: 21464195
    [Abstract] [Full Text] [Related]

  • 35. Vaccines against influenza A (H1N1) pandemic.
    Valdespino-Gomez JL, Garcia-Garcia L, de León-Rosales SP.
    Arch Med Res; 2009 Nov 08; 40(8):693-704. PubMed ID: 20304259
    [Abstract] [Full Text] [Related]

  • 36. Early post-transplant vaccination with pandemic influenza A/H1N1 vaccine in pediatric heart transplant recipients.
    Altamirano-Diaz L, West L, Humar A, Ely L, Urschel S, Gubbay J, Crowcroft N, Kumar D.
    Pediatr Transplant; 2011 Mar 08; 15(2):172-5. PubMed ID: 21176017
    [Abstract] [Full Text] [Related]

  • 37. Acceptance of seasonal and pandemic a (H1N1) 2009 influenza vaccination by healthcare workers in a french teaching hospital.
    Tanguy M, Boyeau C, Pean S, Marijon E, Delhumeau A, Fanello S.
    Vaccine; 2011 Jun 06; 29(25):4190-4. PubMed ID: 21497636
    [Abstract] [Full Text] [Related]

  • 38. DNA-based influenza vaccines: evaluating their potential to provide universal protection.
    Choo AY, Broderick KE, Kim JJ, Sardesai NY.
    IDrugs; 2010 Oct 06; 13(10):707-12. PubMed ID: 20878593
    [Abstract] [Full Text] [Related]

  • 39. Priming with AS03 A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: an open non-randomised extension of a double-blind randomised primary study.
    Leroux-Roels I, Roman F, Forgus S, Maes C, De Boever F, Dramé M, Gillard P, van der Most R, Van Mechelen M, Hanon E, Leroux-Roels G.
    Vaccine; 2010 Jan 08; 28(3):849-57. PubMed ID: 19835828
    [Abstract] [Full Text] [Related]

  • 40. Safety monitoring of Influenza A/H1N1 pandemic vaccines in EudraVigilance.
    Kurz X, Domergue F, Slattery J, Segec A, Szmigiel A, Hidalgo-Simon A.
    Vaccine; 2011 Jun 10; 29(26):4378-87. PubMed ID: 21501644
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.